SlatteryD, ChoudharyP. Clinical use of continuous glucose monitoring in adults with type 1 diabetes. Diabetes Technol Ther, 2017; 19: S55–S61.
5.
CarlsonAL, MullenDM, BergenstalRM. Clinical use of continuous glucose monitoring in adults with type 2 diabetes. Diabetes Technol Ther, 2017; 19: S4–S11.
6.
LalRA, MaahsDM. Clinical use of continuous glucose monitoring in pediatrics. Diabetes Technol Ther, 2017; 19: S37–S43.
7.
WrightEEJr, GavinJR3rd. Clinical use of professional continuous glucose monitoring. Diabetes Technol Ther, 2017; 19: S12–S15.
8.
RodbardD. Continuous glucose monitoring: a review of recent studies demonstrating improved glycemic outcomes. Diabetes Technol Ther, 2017; 19: S25–S37.
9.
SchnellO, BarnardK, BergenstalR, BosiE, GargS, GuerciB, HaakT, HirschIB, JiL, JoshiSR, KampM, LaffelL, MathieuC, PolonskyWH, SnoekF, HomeP. Role of continuous glucose monitoring in clinical trials: recommendations on reporting. Diabetes Technol Ther, 2017; 19: 391–399.
10.
DovčK, BratinaN, BattelinoT. A new horizon for glucose monitoring. Horm Res Paediatr, 2015; 83: 149–156.
11.
SekidoK, SekidoT, KanekoA, HosokawaM, SatoA, SatoY, YamazakiM, KomatsuM. Careful readings for a flash glucose monitoring system in nondiabetic Japanese subjects: individual differences and discrepancy in glucose concentration after glucose loading [Rapid Communication]. Endocr J, 2017; 64: 827–832.
12.
ScaramuzzaAE, ArnaldiC, CherubiniV, PiccinnoE, RabboneI, ToniS, TuminiS, CandelaG, CiprianoP, FerritoL, LenziL, TintiD, CohenO, LombardoF. Recommendations for the use of sensor-augmented pumps with predictive low-glucose suspend features in children: the importance of education. Pediatr Diabetes, 2017; 18: 882–889.
13.
PetruzelkovaL, PickovaK, SumnikZ, SoupalJ, ObermannovaB. Effectiveness of SmartGuard technology in the prevention of nocturnal hypoglycemia after prolonged physical activity. Diabetes Technol Ther, 2017; 19: 299–304.
14.
ScaramuzzaAE, ArnaldiC, CherubiniV, PiccinnoE, RabboneI, ToniS, TuminiS, CandelaG, CiprianoP, FerritoL, LenziL, TintiD, CohenO, LombardoF. Use of the predictive low glucose management (PLGM) algorithm in Italian adolescents with type 1 diabetes: CareLink™ data download in a real-world setting. Acta Diabetol, 2017; 54: 317–319.
15.
PateT, KlemenčičS, BattelinoT, BratinaN. Fear of hypoglycemia, anxiety, and subjective well-being in parents of children and adolescents with type 1 diabetes. J Health Psychol, 2016Jun7; pii: 1359105316650931. DOI 10.1177/1359105316650931 [Epub ahead of print].
16.
BratinaN, ShalitinS, PhillipM, BattelinoT. Type 1 Diabetes in the young: organization of two national centers in Israel and Slovenia. Zdr Varst, 2015; 54: 139–145.
17.
StemMS, DunbarGE, JacksonGR, FarsiuS, Pop-BusuiR, GardnerTW. Glucose variability and inner retinal sensory neuropathy in persons with type 1 diabetes mellitus. Eye (Lond), 2016; 30: 825–832.
18.
KwaiNC, ArnoldR, PoyntenAM, KrishnanAV. Association between glycemic variability and peripheral nerve dysfunction in type 1 diabetes. Muscle Nerve, 2016; 54: 967–969.
19.
GómezAM, Marín CarrilloLF, Arévalo CorreaCM, Muñoz VelandiaOM, Rondón SepúlvedaMA, Silva HerreraJL, Henao CarrilloDC. Maternal-Fetal Outcomes in 34 pregnant women with type 1 diabetes in sensor-augmented insulin pump therapy. Diabetes Technol Ther, 2017; 19: 417–422.
20.
GómezAM, Marín CarrilloLF, Muñoz VelandiaOM, Rondón SepúlvedaMA, Arévalo CorreaCM, Mora GarzónE, Cuervo DiazMC, Henao CarrilloDC. Long-term efficacy and safety of sensor augmented insulin pump therapy with low-glucose suspend feature in patients with type 1 diabetes. Diabetes Technol Ther, 2017; 19: 109–114.
21.
ForlenzaGP, ArgentoNB, LaffelLM. Practical considerations on the use of continuous glucose monitoring in pediatrics and older adults and nonadjunctive use. Diabetes Technol Ther, 2017; 19: S13–S20.
22.
GianiE, SnelgroveR, VolkeningLK, LaffelLM. Continuous glucose monitoring (CGM) adherence in youth with type 1 diabetes: associations with biomedical and psychosocial variables. J Diabetes Sci Technol, 2017; 11: 476–483.
23.
PolonskyWH, HesslerD, RuedyKJ, Beck RW; DIAMOND StudyGroup. The impact of continuous glucose monitoring on markers of quality of life in adults with type 1 diabetes: further findings from the DIAMOND randomized clinical trial. Diabetes Care, 2017; 40: 736–741.
24.
KlemenčičS, de WitM, RutarM, BattelinoT, BratinaN. Annual psychological screening in youth and young adults with type 1 diabetes. Zdr Varst, 2015; 54: 103–111.
25.
LitchmanML, AllenNA. Real-time continuous glucose monitoring facilitates feelings of safety in older adults with type 1 diabetes: a qualitative study. J Diabetes Sci Technol, 2017; 11: 988–995.
26.
HirschIB, BaloAK, SayerK, GarciaA, BuckinghamBA, PeyserTA. A simple composite metric for the assessment of glycemic status from continuous glucose monitoring data: implications for clinical practice and the artificial pancreas. Diabetes Technol Ther, 2017; 19: S38–S48
27.
GrahamC. Continuous glucose monitoring and global reimbursement: an update. Diabetes Technol Ther, 2017; 19: S60–S66.